An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding

• Egile Nagusiak: Ka Man Yip (Egilea), Kwan Ming Lee (Egilea), Tzi Bun Ng (Egilea), Shujun Xu (Egilea), Ken Kin Lam Yung (Egilea), Shaogang Qu (Egilea), Allen Ka Loon Cheung (Egilea), Stephen Cho Wing Sze (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2022-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Since the outbreak of COVID-19 has resulted in over 313,000,000 confirmed cases of infection and over 5,500,000 deaths, substantial research work has been conducted to discover agents/ vaccines against COVID-19. Undesired adverse effects were observed in clinical practice and com...